Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Medicine is Scopus-indexed (Q1, CiteScore 5.7), WoS SCIE, DOAJ. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 2045-7634Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 69 / 361 | 80th | Q1 |
| Oncology | 127 / 428 | 70th | Q2 |
| Cancer Research | 105 / 233 | 55th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q1, CiteScore 5.7.
Cancer Medicine is Q1 in Radiology, Nuclear Medicine and Imaging (rank 69 of 361), Q2 in Oncology (rank 127 of 428) and Q2 in Cancer Research (rank 105 of 233), by CiteScore 2025.
Cancer Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.7, which places it in quartile Q1 at the 80th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.156, quartile Q1, with an H-index of 105.
The publisher lists an article processing charge of about US$4,700 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cancer Medicine is published by John Wiley and Sons Inc. Its ISSN is 2045-7634.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Cancer Medicine has an h-index of 125 and a 2-year mean of 3.78 citations per paper (OpenAlex). Its Scopus CiteScore is 5.7, quartile Q1. On 2-year citations it ranks #47 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Cancer Medicine published 1,016 papers in 2025; its busiest recent year was 2023 with 1,295. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (45.3%), United States (18.5%) and Japan (7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 73 retracted papers are recorded (7.4 per 1,000 papers). The Problematic Paper Screener flags 4 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.